122 related articles for article (PubMed ID: 2471012)
21. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
[TBL] [Abstract][Full Text] [Related]
23. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
[TBL] [Abstract][Full Text] [Related]
24. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
Young RA; Brogden RN
Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
[TBL] [Abstract][Full Text] [Related]
25. Effects of alpha 1-inhibition on lipid metabolism in the rat.
Woodside WF; Swindell AC
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S27-34. PubMed ID: 2447438
[TBL] [Abstract][Full Text] [Related]
26. Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
Jansen H; Baggen RG
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S16-20. PubMed ID: 2447435
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
Hamilton CA; Reid JL; Vincent J
Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
[TBL] [Abstract][Full Text] [Related]
28. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
[TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacotherapeutics of doxazosin.
Taylor SH
Am J Med; 1989 Aug; 87(2A):2S-11S. PubMed ID: 2569822
[TBL] [Abstract][Full Text] [Related]
30. Effect of doxazosin on cholesterol synthesis in cell culture.
D'Eletto RD; Javitt NB
J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S1-4; discussion S4. PubMed ID: 2471008
[TBL] [Abstract][Full Text] [Related]
31. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
Pool JL
Am Heart J; 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PubMed ID: 1824647
[TBL] [Abstract][Full Text] [Related]
32. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
Pool JL; Lenz ML; Taylor AA
J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
[TBL] [Abstract][Full Text] [Related]
33. Studies with doxazosin on the saturable binding of 125I-LDL by liver in normocholesterolemic mice.
Nanjee MN; Miller NE
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S35-41. PubMed ID: 2447439
[TBL] [Abstract][Full Text] [Related]
34. Altered adrenergic control in hypercholesterolemia.
Ohanian J; Nicolosi RJ; Vatner SF; Graham RM; Kowala MC; Young MA
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S11-5. PubMed ID: 2447434
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
36. Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.
Jatwa R; Kar A
Eur J Pharmacol; 2006 Dec; 551(1-3):87-91. PubMed ID: 17027746
[TBL] [Abstract][Full Text] [Related]
37. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
Torvik D; Madsbu HP
Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
[TBL] [Abstract][Full Text] [Related]
38. Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat.
Chichester CO; Rodgers RL
J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S21-6. PubMed ID: 2447437
[TBL] [Abstract][Full Text] [Related]
39. Dietary cholesterol affects serum lipids, lipoproteins and LDL metabolism in cynomolgus monkeys in a dose-dependent manner.
Stucchi AF; Nicolosi RJ; Karge WH; Ausman LM; Ordovas JM
J Nutr; 1998 Jul; 128(7):1104-13. PubMed ID: 9649592
[TBL] [Abstract][Full Text] [Related]
40. Effects of the selective alpha 1-antagonist, doxazosin, on hepatic lipid levels and metabolism in the golden hamster.
Jansen H; Birkenhäger JC
J Cardiovasc Pharmacol; 1991 Sep; 18(3):354-60. PubMed ID: 1720835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
